Latest Operational Cash Flow News

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

EZZ Life Science Holdings delivered a robust Q2 FY25 with a 16.6% increase in customer receipts and a 308% jump in operating cash flows, while gearing up for US market entry and expanding its global footprint.

SelfWealth Ltd reported a 4% revenue increase and sustained profitability in H1 2025, while advancing a major transformation program and entering a proposed acquisition deal with Bell Financial Group.

Regis Resources delivered a robust December quarter with 101.3koz gold production at $2,317/oz AISC, repaid $300 million debt early, and set a promising Exploration Target at Ben Hur.

NuEnergy Gas Limited reported a $279,000 net cash outflow from operations in Q4 2024, maintaining a solid cash balance of $4.89 million. The company continues to rely on loans and capital management to fund its coal bed methane exploration activities.

Range International Limited delivered a standout Q4 2024 with record sales revenue from its Re>Pal Indonesia operations, alongside improved margins and positive cash flow, signaling a robust turnaround.

Spectur Limited reported a robust net cash inflow from operating activities of $2.53 million in Q4 2024, offsetting modest outflows in investing and financing activities. The company closed the quarter with $869,000 in cash and cash equivalents, signaling operational resilience in the surveillance technology sector.

Spectur Limited reports a steady increase in revenue and positive operating cash flow for Q2 FY25, signaling progress in its strategic shift towards profitability. Cost-cutting initiatives and recurring revenue growth underpin expectations for consistent profits in the coming quarters.

Pantoro Limited delivered a solid December quarter with gold production within guidance and positive cash flows for the fourth consecutive quarter, prompting an upward revision to its FY2025 production target. The company’s strategic focus on underground expansion and asset optimisation underpins its growth trajectory.

Bubs Australia has reported a strong Q2 FY25 performance with a positive EBITDA turnaround and robust revenue growth, while advancing its critical FDA clinical trial in the US.

Evolution Mining delivered a standout December quarter with record cash flows, improved safety, and regulatory approval extending Cowal’s mine life to 2042. The company’s growth projects, including the Mungari mill expansion, are progressing ahead of schedule and under budget, positioning Evolution strongly for FY25.

West African Resources Limited reported a robust cash position of A$391.7 million at the end of December 2024, despite significant outflows driven by exploration and operational costs. The company maintains substantial financing facilities, positioning it well for ongoing development.